EXTON, Pa.,Nov. 7 /CNW/ -- Melior Discovery, Inc.announced today that it has signed a research collaboration with Merck & Co., Inc.to evaluate the activity of select Merck neuroscience compounds utilizing elements of Melior’s invivo Indication Discovery platform.
